SCHEMBL19396809

SCHEMBL19396809

c1ccc(-c2ccc(-c3ccc(N(c4ccccc4)c4ccc5c6ccccc6c6ccccc6c6ccccc6c6c(ccc7c8ccccc8oc76)c5c4)cc3)cc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 3/20 0.37
PLA2G2A P14555 4/20 0.35
PLA2G4A P47712 4/20 0.35
MEN1 O00255 3/20 0.35
MAPT P10636 3/20 0.35
HPGD P15428 3/20 0.35
KMT2A Q03164 3/20 0.35
CYP3A4 P08684 2/20 0.35
KDM4E B2RXH2 2/20 0.35
ALPI P09923 1/20 0.35
GAA P10253 1/20 0.35
PKM P14618 1/20 0.35
CASP3 P42574 1/20 0.35
RECQL P46063 1/20 0.35
BLM P54132 1/20 0.35
CASP7 P55210 1/20 0.35
CASP6 P55212 1/20 0.35
MCL1 Q07820 1/20 0.35
HSD17B10 Q99714 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19396365 1.00 ALOX5 (0.37) ALOX5PLA2G2APLA2G4AMEN1MAPT
SCHEMBL19396910 0.99 ALOX5 (0.38) ALOX5PLA2G2APLA2G4AMEN1MAPT
SCHEMBL19396909 0.99 ALOX5 (0.38) ALOX5PLA2G2APLA2G4AMEN1MAPT
SCHEMBL19396839 0.95 MAPT (0.37) ALOX5PLA2G2APLA2G4AMEN1MAPT
SCHEMBL19397007 0.95 AHR (0.37) ALOX5PLA2G2APLA2G4AMEN1MAPT
SCHEMBL19396380 0.95 MAPT (0.37) ALOX5PLA2G2APLA2G4AMEN1MAPT
SCHEMBL19396646 0.95 AHR (0.37) ALOX5PLA2G2APLA2G4AMEN1MAPT
SCHEMBL19397108 0.95 MAPT (0.38) ALOX5MEN1MAPTHPGDKMT2A
SCHEMBL19396690 0.95 MAPT (0.38) ALOX5MEN1MAPTHPGDKMT2A
SCHEMBL19396848 0.95 MAPT (0.38) ALOX5MEN1MAPTHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170279050-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2017-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170279050-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME ESRRA, ESRRB, RCOR3 ALOX5 4064/4885PLA2G2A 4500/4885PLA2G4A 4323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.